Key result
Black race was associated with lower odds of 2-year mortality compared to white race among patients with more severe kidney disease after AMI, despite similar overall mortality (38.1% vs 38.6%, p=0.6).
Why the study?
Does black race compared to white race affect 2-year mortality in patients with incident AMI across different categories of kidney function?
Cohort (n=54,150)
Yes
Does black race compared to white race affect 2-year mortality in patients with incident AMI across different categories of kidney function?
Absolute Event Rate: 38.1% vs 38.6%
p-value: p=0.6
Among patients with incident AMI and severe kidney disease, black patients had better 2-year survival compared to white patients, suggesting racial disparities in ESRD incidence may partly reflect survival differences.
No takes yet. Share an insight, caveat, or question.
Association in severe kidney disease may reflect survival bias; leaves open whether race modifies post-AMI mortality by kidney function.
Newsome et al. (2005) conducted a cohort in Acute myocardial infarction and kidney disease (n=54,150). Black race vs. White race was evaluated on 2-year mortality (p=0.6). Black race was associated with lower odds of 2-year mortality compared to white race among patients with more severe kidney disease after AMI, despite similar overall mortality (38.1% vs 38.6%, p=0.6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: